Home
Argenica Therapeutics Ltd
Safety Review Committee Approves Second Cohort
Business
Nov 2 2022
5 min read

Safety Review Committee Approves Second Cohort

news images

Argenica Therapeutics Ltd has released a press release.

View Attachment